April 24, 2014

As part of the launch of DSN’s new microsite, DrugStoreNews.com/Pain-Management, DSN had the opportunity to speak with Carmen Catizone, executive director of the National Association of Boards of Pharmacy, regarding a new initiative that the association is spearheading to address the current patient access problem when it comes to pain management pharmaceuticals.

January 23, 2014

In a recent report, 59News explored how DEA regulations on pain medications can limit a pharmacy's supply, preventing patients from obtaining their medications.

January 8, 2014

News stories about doctor shopping and prescription pad pilfering in pursuit of a pain-pill induced high have become commonplace, prompting many legislators and regulators to consider further restrictions on pain medicines like hydrocodone compounds. But there may be a story that’s not being told — that the patients who suffer from chronic pain and need that hydrocodone to reclaim their lives are being stigmatized. The prevalence of pain pill abuse has left in its wake as many as 116 million legitimate pain sufferers who are finding it more difficult to access their therapies.

January 2, 2014

One reason pain patient advocates are so passionate about what they do is because they are pain patients themselves — they know the stigma associated with chronic pain; they know how difficult it can be to access appropriate pain therapy sometimes. That’s the story of Gina Libby, volunteer pain patient advocate who has lived with chronic pain for more than 20 years.

July 14, 2016

Aleve Direct Therapy is indicated for the temporary relief of pain associated with sore and aching muscles in the lower back due to strain from exercise or normal household and work activities.

June 22, 2016

There are 38 million migraine sufferers in the U.S., and 75% report that weather pressure changes trigger their attacks, and Cirrus Healthcare Products' new app is looking to help people #killmigraines. 

June 20, 2016

To help clinicians and patients make informed decisions about aspirin use, researchers at Brigham and Women's Hospital have developed a new, free, mobile app, "Aspirin-Guide" that calculates both the cardiovascular disease risk score and the bleeding risk score for an individual patient, and helps clinicians decide which patients are appropriate candidates for the use of low-dose aspirin (75 to 81 mg daily).

June 9, 2016

MigraineX provides relief for migraine and headache symptoms in 81% of sufferers when paired with regular migraine medication, according to data from a clinical study conducted by Princeton Consumer Research.

June 6, 2016

A CHPA survey found that the number of consumers who understand that exceeding the recommended daily dose of acetaminophen may lead to liver damage has increased from 78% in 2010 to 87% in 2013. 

June 1, 2016

Gaps in products on the market, especially those in packaging appealing to children, helped Hyland’s revamp existing products and create new products.

April 27, 2016

Aspergum is a chewable aspirin product indicated to soothe sore throats, control fevers and provide all over pain relief.  

April 20, 2016

Hyland's helps marathoners be 'Boston Strong' by supplying Leg Cramps products in all pre-race, on-course and post-race medical tents.

April 12, 2016
Oska Pulse is selling for a suggested retail price of $399.
April 7, 2016

In 2014, 123 million prescriptions were filled for NSAIDs in the U.S., and it is reported that one-third of the general population have used OTC NSAIDs. 

April 6, 2016

The Migraine Experience is the first simulator designed to give non-sufferers the chance to safely experience symptoms of a migraine including disorientation, aura, sensitivity to light and blurred vision. 

March 17, 2016

The Wearable Tech award honors “new hardware that revolutionizes the convenience, comfort, functionality, efficiency and fashion of having a device literally ‘on you.’” 

March 7, 2016

The researchers estimate that regular aspirin use could prevent close to 30,000 gastrointestinal tract tumors in the U.S. each year.

March 2, 2016

The device now has 25% more battery life and is more integrated with the Quell Relief smartphone app, allowing users to manage their pain and see insights about their sleep patterns. 

February 26, 2016

Quell is an over-the-counter device for relief of chronic pain. This wearable device utilizes NeuroMetrix's patented neurostimulation technology to provide pain relief. 

February 22, 2016

The active ingredient from Mycratine is nicotine, a naturally occurring molecule found in eggplant, cauliflower, tomatoes and potatoes.

February 4, 2016
Salonpas includes three active ingredients - camphor (3.1%), menthol (10%) and methyl salicylate (15%) - which provide temporary relief of minor aches and pains.
January 4, 2016

Quell is an easy-to-use, over-the-counter device for relief of chronic pain that NeuroMetrix launched at last year's CES conference. 

December 7, 2015

Cirrus Healthcare Products has created a new migraine relief product that is clinically proven to reduce the duration, intensity and discomfort of migraine headaches.

November 20, 2015

The Food and Drug Administration on Monday issued new warning labeling guidance for medicines containing acetaminophen, according to a blog posted by the Regulatory Affairs Professionals Society. "The guidance ... helps to clarify certain cases where manufacturers of internal analgesic, antipyretic and antirheumatic OTC drugs would be able to change liver warnings when the product's directions for use result in a maximum daily dose of acetaminophen that is less than 4,000 mg for adults," wrote Zachary Brennan. (RAPS